Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Head and Neck Neoplasms 2 Salivary Gland Neoplasms 1 Recurrence 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Klatskin Tumor 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 51 Gemcitabine 26 toripalimab 20 Radiotherapy, Intensity-Modulated 19 Fluorouracil 16 Capecitabine 16 camrelizumab 15 Docetaxel 14 nimotuzumab 12 Radiotherapy 10 Drug Therapy 10 apatinib 9 Nivolumab 9 sintilimab 8 endostar protein 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Immune Checkpoint Inhibitors 7 tislelizumab 6 spartalizumab 6 Chemoradiotherapy 6 Cetuximab 6 Bevacizumab 6 pembrolizumab 5 nedaplatin 5 S 1 (combination) 5 Radiation 5 Paclitaxel 5 Endostatins 5 anlotinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nasopharyngeal Carcinoma × temoporfin × Clear all

NCT01086488 2011-07-08

FOSCAN

Ministry of Health, Malaysia

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡